RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @interfluidity: treatment rather than vaccination is the big pharma conspiracy. better to manage than to cure, better to cure than to pr…
For this reason, government need to just buy vaccines up in relevant amounts or buy IP from companies and produce it itself.
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
@ewarren @SenSanders @RepKatiePorter so people think its better to get treated for a desease than prevent it through vaccination. Thank you big Pharma for keeping the cost of health care high @USProgressives @ConnieSchultz @SenSherrodBrown worth an OP-ed
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @interfluidity: treatment rather than vaccination is the big pharma conspiracy. better to manage than to cure, better to cure than to pr…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
Een redelijk leesbaar stuk over de voordelen van medicijnen (behandeling v.e. ziekte) boven vaccins (preventie). Voor "Big Pharma", wel te verstaan.
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
Duh, yes. The Big Pharma Commandments! 1. Cure is more profitable than prevention. 2. “Treatment” is more profitable than cure. 3. Lifelong treatments with complicated side effects are even more profitable. They create more sickness than they treat.
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @interfluidity: treatment rather than vaccination is the big pharma conspiracy. better to manage than to cure, better to cure than to pr…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @interfluidity: treatment rather than vaccination is the big pharma conspiracy. better to manage than to cure, better to cure than to pr…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @interfluidity: treatment rather than vaccination is the big pharma conspiracy. better to manage than to cure, better to cure than to pr…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @interfluidity: treatment rather than vaccination is the big pharma conspiracy. better to manage than to cure, better to cure than to pr…
treatment rather than vaccination is the big pharma conspiracy. better to manage than to cure, better to cure than to prevent, financially speaking. vaccines prevent.
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
Wait! Is there a name for this kind of market failure where the incentives are to develop temporary, re-purchasable 'treatments' of problems rather than long-preventatives to 'problems'? This is not an externality, public good undersupply, or information a
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…
RT @ColinJMcAuliffe: Big pharma chronically underinvests in vax development because often it is much less profitable to prevent disease tha…